AI vs. doctor: the race to save sight in routine checkups

NCT ID NCT07069647

Summary

This study is testing whether artificial intelligence (AI) software can help family doctors and geriatric specialists better screen for two common causes of vision loss: diabetic eye disease and age-related macular degeneration. About 4,300 adults with diabetes or over age 50 will be randomly assigned to have their eye scan analyzed by the AI tool with immediate results or by a doctor alone. The goal is to see if the AI helps find more cases earlier, leading to faster referrals to eye specialists and better treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Taiwan University Hospital

    RECRUITING

    Taipei, 100225, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.